Abstract
Background/Objective Endometrial (EM) biopsy is a commonly-performed gynecological procedure that is associated with side effects such as discomfort and pain. The aim of the current study was to predict procedural pain during EM biopsy.
Methods We retrospectively reviewed the medical records of 100 women who underwent EM biopsy between July 2014 and November 2015 in an outpatient clinic of our hospital. Eighty-one patients were included in the final analysis after excluding those who lacked pain data and those who were sedated with midazolam. We examined the association of patient and clinician characteristics with procedural pain, and created a prediction model using characteristics via multiple linear regression analysis.
Results Eighty-one women underwent EM biopsy (dilatation and curettage, EM sampling). In univariable analysis, history of EM biopsy, endometrial thickness (EMT) and training year of operator (TY) were significantly associated with procedural pain. The initial multivariable model was fitted with significant predictors in a univariable analysis. The p-value of EMT and TY was below the pre-defined threshold (0.2) and the final pain prediction model included EMT and TY. Furthermore, pain during the procedure was calculated by the following equation: pain score (numeric rating scale) = 7.364 + (−0.872) * EM thickness (cm) + (−1.033)*TY.
Conclusion Both endometrial thickness and training year of operator were useful predictors of the severity of EM biopsy-related pain.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding was obtained for preparation of this manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Institutional review board of Seoul National University Bundang Hospital and the requirement for informed consent was waived (B-1606-349-111).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The minimal data set underlying the findings in our study data is within the paper.
